The genetics of type 2 diabetes
How gene variants shape risk and insulin biology, including work on CACNA1E and adrenergic receptors.
Precision diabetes, explained.
The science of diabetes, made clear
Plain-language explainers on the genetics and biology of type 2 diabetes, by Dr. Damon Tojjar, physician-scientist. For education, not medical advice.
Topics
Grounded in real research.
Insulin secretion and beta-cell biology
Why the beta cell sits at the center of type 2 diabetes.
Ethnic differences in diabetes risk
What a large meta-analysis tells us about insulin sensitivity and response across populations.
AI decision support in the clinic
How evidence becomes a tool clinicians can use, as in EASY Diabetes.
Explainer
Why ethnic differences matter in type 2 diabetes risk.
Type 2 diabetes does not affect every population in the same way. People of different ancestral backgrounds can develop the disease at different body weights, at different ages, and through different balances of two core problems: how sensitive the body is to insulin, and how much insulin the pancreas can release in response.
In a systematic review and meta-analysis published in Diabetes Care, Dr. Tojjar and colleagues examined how the relationship between insulin sensitivity and insulin response varies across ethnic groups. The pattern matters clinically. Two people with the same blood sugar can be there for different underlying reasons, which means the most useful prevention and treatment strategy can differ as well.
Why does this happen? Part of the answer is genetic. Variants in genes that govern insulin secretion, including ion channels and receptors studied in Dr. Tojjar's earlier work, differ in frequency across populations. Part is metabolic and environmental. The practical lesson is that a single global threshold can miss real differences in risk, and that precision medicine, tailoring screening and treatment to the individual, is not a luxury but a route to better outcomes.
This is also why clinical decision support matters. A tool like EASY Diabetes can hold this nuance in the background and help a clinician choose the right next step for the person in front of them, rather than the average patient. The meta-analysis is the evidence; the decision-support system is one way that evidence reaches the clinic.
This explainer is for education and is not medical advice. For care, consult a qualified clinician.
About the author. Dr. Damon Tojjar is a physician-scientist (M.D., Ph.D. candidate) and digital health entrepreneur. Read more at damontojjar.com.
- ScienceOverexpression of alpha2A-adrenergic receptors contributes to type 2 diabetesTojjar, D. (shared / co-second author). Magnus Blix Award.doi.org/10.1126/science.1176827
- Diabetes CareEthnic differences in the relationship between insulin sensitivity and insulin responseTojjar, D. (co-author). Systematic review and meta-analysis. Widely cited.doi.org/10.2337/dc12-1235
- DiabetologiaPolymorphisms in the Ca2+ channel CaV2.3 (CACNA1E) and type 2 diabetesTojjar, D. (co-author). Gene discovery and impaired insulin secretion.doi.org/10.1007/s00125-007-0846-2
- Diabetes, Obesity and MetabolismComparison of insulin degludec with insulin detemir in type 1 diabetesTojjar, D. (co-author). One-year treat-to-target trial.doi.org/10.1111/dom.12573
Frequently asked
About diabetes science.
Why do ethnic differences matter in type 2 diabetes?
Because insulin sensitivity and insulin response can differ across populations, the same blood sugar can have different underlying causes. A Diabetes Care meta-analysis co-authored by Dr. Tojjar examined this, supporting a more individualized, precision-medicine approach.
Who writes these explainers?
Dr. Damon Tojjar, a physician-scientist (M.D., Ph.D. candidate) whose peer-reviewed research focuses on the genetics and biology of type 2 diabetes.